Condition (MeSH)
Angioid Streaks
ClinicalTrials.gov lists 11 trials for Angioid Streaks or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
11 of the 11 trials are tagged with Angioid Streaks itself; the rest are tagged with a narrower condition beneath it.
When did Angioid Streaks trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2018 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2010 | 1 |
| 2009 | 1 |
| 2007 | 1 |
| 2006 | 1 |
| 2005 | 2 |
| 2000 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 11 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Angioid Streaks trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Not applicable | 2 |
| Observational | 2 |
How many Angioid Streaks trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 5 |
| Terminated | 1 |
| Withdrawn | 3 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 2.0 aflibercept | 2 |
| Intravitreal Injection | 2 |
| Bevacizumab 1 | 2 |
| Intravitreal injection ranibizumab | 1 |
| Intravitreal Bevacizumab | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Angioid Streaks? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. | Retina (Philadelphia, Pa.) | 2013 | Yes |
| Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. | American journal of ophthalmology | 2011 | Yes |
| Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. | Investigative ophthalmology & visual science | 2009 | Yes |
| Fundus autofluorescence in Pseudoxanthoma elasticum. | Retina (Philadelphia, Pa.) | 2009 | Yes |
| Pseudoxanthoma elasticum: biopsy of clinically normal skin in the investigation of patients with angioid streaks. | The British journal of dermatology | 2007 | Yes |
Showing 5 of 10 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.